Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Antiviral Res ; 216: 105672, 2023 08.
Article in English | MEDLINE | ID: mdl-37453453

ABSTRACT

Data on herpes simplex virus (HSV) polymorphism as well as acyclovir (ACV) and foscarnet (FOS) resistance mutations are not exhaustive and may hinder accurate diagnosis by next-generation sequencing (NGS). Here, we report novel UL23 and UL30 substitutions for HSV1 and HSV2 identified in immunocompromised patients treated for hematological malignancies during the last 6 years of HSV resistance surveillance at the University Hospital of Lyon. For HSV1, 35 novel UL23 substitutions and 52 novel UL30 substitutions were identified. For HSV2, 2 novel UL23 substitutions and 12 novel UL30 substitutions were identified. These results allow to complete the database of HSV1 and HSV2 substitutions, related either to polymorphism or to ACV and FOS resistance.


Subject(s)
Herpes Simplex , Herpesvirus 1, Human , Humans , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Herpes Simplex/drug therapy , Herpesvirus 1, Human/genetics , Viral Proteins/genetics , Drug Resistance, Viral/genetics , Acyclovir/pharmacology , Acyclovir/therapeutic use , Foscarnet/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...